Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma.

被引：0
|
作者：
Gertz, MA [1 ]
Lacy, MQ [1 ]
Gastineau, DA [1 ]
Inwards, DJ [1 ]
Tefferi, A [1 ]
Chen, M [1 ]
Litzow, MR [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2573
引用
收藏
页码：577A / 577A
页数：1
相关论文
共 50 条
  • [1] Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma
    MA Gertz
    MQ Lacy
    DJ Inwards
    DA Gastineau
    A Tefferi
    MG Chen
    TE Witzig
    PR Greipp
    MR Litzow
    [J]. Bone Marrow Transplantation, 2000, 26 : 45 - 50
  • [2] Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma
    Gertz, MA
    Lacy, MQ
    Inwards, DJ
    Gastineau, DA
    Tefferi, A
    Chen, MG
    Witzig, TE
    Greipp, PR
    Litzow, MR
    [J]. BONE MARROW TRANSPLANTATION, 2000, 26 (01) : 45 - 50
  • [3] Second autologous stem cell transplantation as a strategy for management of relapsed multiple myeloma.
    Gonsalves, Wilson I.
    Kumar, Shaji
    Lacy, Martha
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Buadi, Francis
    Dingli, David
    Hogan, William J.
    Gertz, Morie A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] High-dose lenalidomide and melphalan as conditioning for autologous stem cell transplantation in relapsed or refractory multiple myeloma.
    Rossi, Adriana C.
    Monge, Jorge
    Niesvizky, Ruben
    Hsu, Jing Mei
    Shore, Tsiporah
    Van Besien, Koen
    Pearse, Roger
    Mark, Tomer
    Jayabalan, David
    Mayer, Sebastian Alexander
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Autologous peripheral blood stem cell transplantation for primary refractory multiple myeloma.
    Kumar, S
    Lacy, MQ
    Dispenzieri, A
    Rajkumar, SV
    Fonseca, R
    Geyer, S
    Iturria, N
    Allmer, C
    Lust, JA
    Witzig, TE
    Greipp, PR
    Kyle, RA
    Litzow, MR
    Gertz, MA
    [J]. BLOOD, 2002, 100 (11) : 432A - 433A
  • [6] Delayed stem cell transplantation in patients with relapsed or refractory multiple myeloma using thalidomide as a preparative regimen.
    Dmoszynska, A
    Hus, M
    Legiec, W
    Walter-Croneck, A
    Wach, M
    [J]. BLOOD, 2000, 96 (11) : 368B - 368B
  • [7] Outcome of Autologous Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Multiple Myeloma
    Veltri, Lauren Westfall
    Milton, Denai R.
    Shah, Nina
    Patel, Krina
    Nieto, Yago
    Kebriaei, Partow
    Popat, Uday R.
    Parmar, Simrit
    Oran, Betul
    Ciurea, Stefan O.
    Hosing, Chitra
    Lee, Hans
    Manasanch, Elisabet E.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    [J]. BLOOD, 2016, 128 (22)
  • [8] Evaluation of gemcitabine in relapsed or refractory multiple myeloma.
    Leleu, X
    Troncy, J
    Micol, JB
    Bouafia, F
    Guieze, R
    Yakoub-Agha, I
    Depil, S
    Kuhnovski, F
    Terriou, L
    Michallet, M
    Facon, T
    Dumontet, C
    [J]. BLOOD, 2003, 102 (11) : 384B - 384B
  • [9] Non-myeloablative allogeneic transplantation in patients with relapsed or refractory multiple myeloma.
    Gerull, S
    Hegenbart, U
    Goerner, M
    Benner, A
    Moehler, T
    Goldschmidt, H
    Ho, AD
    [J]. BLOOD, 2004, 104 (11) : 755A - 755A
  • [10] Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?
    Park, Hyunkyung
    Byun, Ja Min
    Yoon, Sung-Soo
    Koh, Youngil
    Shin, Dong-Yeop
    Hong, Junshik
    Kim, Inho
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (08) : 1 - 13
12345